Verdemed nabs $17 mln to bring medical cannabis to Latin America
Verdemed Holdings Inc, a Toronto-based medical cannabis company, has raised about $17 million (US$12.7 million) of mostly equity and convertible debt financing. The funding came from unidentified private investors located in Latin America. Led by President and CEO José Bacellar, Verdemed aims to provide a wide range of cannabinoid-based medications to address unmet clinical needs in Latin American countries. The company will use the deal's proceeds to acquire production assets in Colombia and Brazil and develop its business plans in Chile and Mexico.
17 April 2019•4 mins read
